Improvement of correlation between oral dose of cyclosporine and cyclosporinemia after substitution of cyclosporine standard presentation by cyclosporine microemulsion one, in 1345 patients with kidney transplantation. Spanish Sandimmune Neoral Conversion Group.
作者信息
Gentil Govantes M A, Gómez Ullate P, Errasti P, Fernández Fresnedo G, Capdevila L, Sanz Guajardo A, Cubero J J
机构信息
H. Virgen del Rocico, Sevilla, Spain.
出版信息
Transplant Proc. 1998 Aug;30(5):1658-9. doi: 10.1016/s0041-1345(98)00380-7.
PMID:9723231
Abstract
摘要
相似文献
1
Improvement of correlation between oral dose of cyclosporine and cyclosporinemia after substitution of cyclosporine standard presentation by cyclosporine microemulsion one, in 1345 patients with kidney transplantation. Spanish Sandimmune Neoral Conversion Group.
Transplant Proc. 1998 Aug;30(5):1658-9. doi: 10.1016/s0041-1345(98)00380-7.
2
A critical appraisal of cyclosporine A pharmacokinetics in pediatric kidney transplantation using a microemulsion galenic formulation (Neoral).
Transplant Proc. 1998 Aug;30(5):1666-7. doi: 10.1016/s0041-1345(98)00384-4.
3
Neoral versus Sandimmune in kidney transplantation.肾移植中，新山地明与环孢素的对比
Transplant Proc. 1998 Aug;30(5):1749-50. doi: 10.1016/s0041-1345(98)00414-x.
4
Conversion from Sandimmune to Neoral in renal transplant recipients: two-year experience.肾移植受者从山地明转换为新山地明：两年经验
Transplant Proc. 1998 Aug;30(5):1753-5. doi: 10.1016/s0041-1345(98)00416-3.
5
Conversion from Sandimmune to Neoral and induction therapy with Neoral in pediatric renal transplant recipients.
Transplant Proc. 1996 Aug;28(4):2259-61.
6
Conversion from Sandimmune to Neoral in patients with stable renal allograft function: UHKL experience.肾移植功能稳定患者从山地明转换为新山地明：香港大学深圳医院的经验。
Transplant Proc. 1998 Nov;30(7):3535-6. doi: 10.1016/s0041-1345(98)01126-9.
7
Randomized, double-blind, one-year study of the safety and tolerability of cyclosporine microemulsion compared with conventional cyclosporine in renal transplant patients. International Sandimmun Neoral Study Group.肾移植患者中，环孢素微乳剂与传统环孢素安全性及耐受性的随机、双盲、为期一年的研究。国际山地明新山地明研究组
Transplantation. 1998 Jun 15;65(11):1455-60. doi: 10.1097/00007890-199806150-00008.
8
Limited sampling strategy to estimate exposure to cyclosporine A in renal allograft recipients treated with Sandimmune-Neoral.
Transplant Proc. 1996 Dec;28(6):3138-9.
9
Cyclosporine pharmacokinetics in renal allograft recipients with diabetes mellitus with Sandimmune and Sandimmune Neoral.
Transplant Proc. 1996 Dec;28(6):3140-1.
10
Nine-month follow-up of SangCya (Sang-35) in kidney transplant patients after conversion from Sandimmune.肾移植患者从赛尼哌转换为赛贝（Sang-35）后的9个月随访
Transplant Proc. 1999 Feb-Mar;31(1-2):324-5. doi: 10.1016/s0041-1345(98)01646-7.
引用本文的文献
1
Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.环孢素：基于微乳剂的制剂（新山地明）在器官移植中药物动力学特性、临床疗效及耐受性的最新综述
Drugs. 2001;61(13):1957-2016. doi: 10.2165/00003495-200161130-00006.
Zotero 插件